Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,535.01
    -1,292.80 (-2.45%)
     
  • CMC Crypto 200

    1,371.97
    +59.35 (+4.52%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.02 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

New Strong Buy Stocks for October 17th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Lithia Motors, Inc. (LAD): This company that operates as an automotive retailer has seen the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

Lithia Motors, Inc. Price and Consensus

 

Lithia Motors, Inc. Price and Consensus
Lithia Motors, Inc. Price and Consensus

Lithia Motors, Inc. price-consensus-chart | Lithia Motors, Inc. Quote

Equitrans Midstream Corporation (ETRN): This company that owns, operates, acquires, and develops natural gas gathering, transmission and storage has seen the Zacks Consensus Estimate for its current year earnings increasing 13.2% over the last 60 days.

ADVERTISEMENT

Equitrans Midstream Corporation Price and Consensus

 

Equitrans Midstream Corporation Price and Consensus
Equitrans Midstream Corporation Price and Consensus

Equitrans Midstream Corporation price-consensus-chart | Equitrans Midstream Corporation Quote

BioDelivery Sciences International, Inc. (BDSI): This specialty pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 22% over the last 60 days.

BioDelivery Sciences International, Inc. Price and Consensus

 

BioDelivery Sciences International, Inc. Price and Consensus
BioDelivery Sciences International, Inc. Price and Consensus

BioDelivery Sciences International, Inc. price-consensus-chart | BioDelivery Sciences International, Inc. Quote

ReneSola Ltd (SOL): This company that develops, builds, operates, and sells solar power projects has seen the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Renesola Ltd. Price and Consensus

 

Renesola Ltd. Price and Consensus
Renesola Ltd. Price and Consensus

Renesola Ltd. price-consensus-chart | Renesola Ltd. Quote

Alleghany Corporation (Y): This company that provides property and casualty reinsurance and insurance products has seen the Zacks Consensus Estimate for its current year earnings increasing 11.2% over the last 90 days.

Alleghany Corporation Price and Consensus

 

Alleghany Corporation Price and Consensus
Alleghany Corporation Price and Consensus

Alleghany Corporation price-consensus-chart | Alleghany Corporation Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.50% per year. So be sure to give these hand-picked 7 your immediate attention.

See them now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alleghany Corporation (Y) : Free Stock Analysis Report
 
Renesola Ltd. (SOL) : Free Stock Analysis Report
 
Lithia Motors, Inc. (LAD) : Free Stock Analysis Report
 
Equitrans Midstream Corporation (ETRN) : Free Stock Analysis Report
 
BioDelivery Sciences International, Inc. (BDSI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research